Institute of Clinical and Molecular Virology

A systems biology approach to identify the combination effects of human herpesvirus 8 genes on NF-κB activation (2009) Konrad A, Wies E, Thurau M, Marquardt G, Naschberger E, Hentschel S, Jochmann R, et al. Journal article The Kaposi's sarcoma-associated herpesvirus-encoded vIRF-3 inhibits cellular IRF-5 (2009) Wies E, Hahn A, Schmidt K, Viebahn C, Rohland N, Lux A, Schellhorn T, et al. Journal article Kaposi's sarcoma-associated herpesvirus gH/gL: glycoprotein export and interaction with cellular receptors. (2009) Hahn A, Birkmann A, Wies E, Dorer D, Mahr K, Stürzl M, Titgemeyer F, Neipel F Journal article Viral inhibitor of apoptosis vFLIP/K13 protects endothelial cells against superoxide-induced cell death (2009) Thurau M, Marquardt G, Britzen-Laurent N, Weinlaender K, Naschberger E, Jochmann R, Alkharsah KR, et al. Journal article Strong induction of 4-1BB, a growth and survival promoting costimulatory receptor, in HTLV-1-infected cultured and patients' T cells by the viral Tax oncoprotein (2008) Pichler K, Kattan T, Gentzsch J, Kreß A, Taylor GP, Bangham CRM, Grassmann R Journal article Interactions of LSECtin and DC-SIGN/DC-SIGNR with viral ligands: Differential pH dependence, internalization and virion binding (2008) Gramberg T, Soilleux E, Fisch T, Lalor PF, Hofmann H, Wheeldon S, Cotterill A, et al. Journal article, Original article Intracellular localization map of human herpesvirus 8 proteins. (2008) Sander G, Konrad A, Thurau M, Wies E, Leubert R, Kremmer E, Dinkel H, et al. Journal article High throughput screening of gene functions in mammalian cells using reversely transfected cell arrays: review and protocol. (2008) Stürzl M, Konrad A, Sander G, Wies E, Neipel F, Naschberger E, Reipschlaeger S, et al. Journal article, Review article PDE-5 inhibition impedes TSP-1 expression, TGF-β activation and matrix accumulation in experimental glomerulonephritis (2008) Hohenstein B, Daniel C, Wittmann S, Hugo C Journal article The viral interferon-regulatory factor-3 is required for the survival of KSHV-infected primary effusion lymphoma cells. (2008) Wies E, Mori Y, Hahn A, Kremmer E, Stürzl M, Fleckenstein B, Neipel F Journal article